Lactose
- Generic Name
- Lactose
- Drug Type
- Small Molecule
- Chemical Formula
- C12H22O11
- CAS Number
- 63-42-3
- Unique Ingredient Identifier
- 3SY5LH9PMK
- Background
A disaccharide of glucose and galactose in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.
- Indication
Not Available
- Associated Conditions
- Asthma, Chronic Obstructive Pulmonary Disease (COPD), Hypothyroidism, Opioid Dependence, Thyroid Cancer
- Associated Therapies
- Maintenance treatment, opioids, Opioid Detoxification
Deanxit and Rivotril in Tinnitus Patients
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2009-08-11
- Lead Sponsor
- University Hospital, Antwerp
- Target Recruit Count
- 50
- Registration Number
- NCT00841230
- Locations
- 🇧🇪
Antwerp University Hospital, Antwerp, Belgium
Cholecalciferol Supplementation, Muscle Strength
Phase 1
Completed
- Conditions
- Vitamin D Deficiency
- Interventions
- First Posted Date
- 2008-05-22
- Last Posted Date
- 2011-06-15
- Lead Sponsor
- Indian Council of Medical Research
- Target Recruit Count
- 40
- Registration Number
- NCT00682214
Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT
Phase 2
Completed
- Conditions
- Obstructive Airway Disease
- Interventions
- Drug: Formoterol/Budesonide
- First Posted Date
- 2008-02-27
- Last Posted Date
- 2013-05-06
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 32
- Registration Number
- NCT00624754
- Locations
- 🇫🇷
Hôpital Saint Louis, Paris, France
Pulmonary Tuberculosis and Vitamin D
- First Posted Date
- 2007-07-25
- Last Posted Date
- 2011-01-27
- Lead Sponsor
- Indian Council of Medical Research
- Target Recruit Count
- 150
- Registration Number
- NCT00507000
- Locations
- 🇮🇳
Depratment of Endocrinology;Medicine, All India Institute of Medical sciences, and DBT, Delhi, New Delhi, India
Pharmacological Modulations of Allergen-Specific Immunotherapy
Phase 3
Completed
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2007-07-20
- Last Posted Date
- 2008-04-11
- Lead Sponsor
- Medical University of Lodz
- Target Recruit Count
- 85
- Registration Number
- NCT00504946
- Locations
- 🇵🇱
Department of Pediatrics and Allergy, Medical University of Lodz Lodz, Poland, Lodz, Poland
St. John's Wort in the Treatment of Raynaud's Phenomenon
- First Posted Date
- 2006-07-12
- Last Posted Date
- 2009-07-14
- Lead Sponsor
- Lawson Health Research Institute
- Target Recruit Count
- 20
- Registration Number
- NCT00351117
- Locations
- 🇨🇦
Rheumatology Clinic, St. Joseph's Health Care, London, Ontario, Canada
MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder
Phase 2
Completed
- Conditions
- Posttraumatic Stress Disorder
- Interventions
- First Posted Date
- 2004-08-25
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Lykos Therapeutics
- Target Recruit Count
- 23
- Registration Number
- NCT00090064
- Locations
- 🇺🇸
Offices of Michael Mithoefer MD, Mount Pleasant, South Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath